Investor Relations

VIDEO SPOTLIGHT


Investor Webinar - Trends in Artificial Intelligence (AI) and Innovators in Healthcare: A Fireside Chat with Perimeter Medical Imaging AI hosted by Martin Gagel, Radius Research

Perimeter B-Series OCT is limited by U.S. law to investigational use and not available for sale in the United States. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. For more information, please visit www.perimetermed.com/disclosures.

Company Overview

About Perimeter Medical Imaging AI, Inc.

Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation, artificial intelligence technology that is currently under clinical development. The company’s ticker symbol “PINK” is a reference to the pink ribbons used during Breast Cancer Awareness Month.

Investor Contact Information

Company

Perimeter Medical Imaging
555 Richmond St W
Suite 511
Toronto, ON M5V 3B1
Toll-Free: (888) 988-7465 (PINK)
T: (214) 845-5154
F: (972) 587-7795
investors@perimetermed.com

Transfer Agent

Computershare
P.O. Box 43078
Providence, RI 02940
https://www.computershare.com

Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.